Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D73FNL
|
|||
| Drug Name |
CX-904
|
|||
| Synonyms |
AMG 651
Click to Show/Hide
|
|||
| Drug Type |
Bispecific T-cell engager
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 1 | [1] | |
| Company |
Amgen
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05387265) A Phase 1/1b, Open-label, Dose-finding, First-in-human Study to Evaluate the Safety and Antitumor Activity of CX-904, an EGFR-targeted T-cell Engager in Advanced Solid Tumors (CTMX-904-101). U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of CytomX | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.